VOLUME AND HETEROGENEITY DEPENDENCE OF THE DOSE-RESPONSE RELATIONSHIP FOR HEAD AND NECK TUMORS

被引:20
作者
CRONQVIST, AKA
KALLMAN, P
TURESSON, I
BRAHME, A
机构
[1] KAROLINSKA INST,DEPT MED RADIAT PHYS,STOCKHOLM,SWEDEN
[2] UNIV STOCKHOLM,STOCKHOLM,SWEDEN
[3] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT ONCOL,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.3109/02841869509127196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Based on the Poisson statistics of cell kill a model for the response of heterogeneous tumours to non-uniform dose delivery have been developed. The five parameters required to characterize the response are the 50% response dose, D-50, the normalized dose-response gradient, gamma, the tumour heterogeneity factor, h, the relative volume, upsilon and the extra daily dose required to counteract the tumour cell proliferation, delta. The model has been fitted to data from a number of clinical investigations to allow the derivation of clinically relevant radiation response parameters for head and neck tumours. The D-50 value for T2 larynx cancers is 59.9 Gy in 41 days with a relative standard deviation of 2.1 Gy and the gamma value is 2.9 with a relative standard deviation of 0.3. The value of delta, which is most consistent with the clinical data for laryngeal tumours, is 0.35 Gy/day and this value should be used if the treatment time is changed from the 41 days normalization. The heterogeneity factor, h, is close to zero for laryngeal tumours which indicates that their response is basically governed by Poisson statistics. Nasopharyngeal tumours, on the other hand, exhibit h values around 0.2 which indicates that these tumours are more heterogeneous in their internal organization and so are their responses to radiation.
引用
收藏
页码:851 / 860
页数:10
相关论文
共 39 条
[1]   OPTIMIZATION OF UNCOMPLICATED CONTROL FOR HEAD AND NECK TUMORS [J].
AGREN, A ;
BRAHME, A ;
TURESSON, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (04) :1077-1085
[2]  
AGREN AK, 1994, IN PRESS MODELLING C
[3]  
ARISTIZABAL SA, 1972, RADIOLOGY, V130, P419
[4]  
BEDWINEK JM, 1980, CANCER, V45, P2725, DOI 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO
[5]  
2-1
[6]   OPTIMAL DOSE DISTRIBUTION FOR ERADICATION OF HETEROGENEOUS TUMORS [J].
BRAHME, A ;
AGREN, AK .
ACTA ONCOLOGICA, 1987, 26 (05) :377-385
[7]   DOSIMETRIC PRECISION REQUIREMENTS IN RADIATION-THERAPY [J].
BRAHME, A .
ACTA RADIOLOGICA ONCOLOGY, 1984, 23 (05) :379-391
[8]  
BRAHME A, 1995, RAD THERAPY PHYSICS
[9]  
BRAHME A, 1994, ION BEAM THERAPY
[10]  
Brahme A, 1988, ACTA ONCOL S, V1, P5